SpyGlass Pharma, Inc. Common Stock (SGP) Earnings Analysis
SpyGlass Pharma, Inc. Common Stock (SGP) next reports earnings on 2026-09-02, consensus EPS -0.51642 USD. Last quarter (2026-05-14) it missed with EPS -0.69 USD vs -0.50311 USD est (-37.1%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -19.20.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SGP next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | -0.51642 USD |
| Revenue estimate | n/a |
SGP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.69 USD | -0.50311 USD | -37.1% | Miss |
| 2026-03-26 | -5.72 USD | -0.57422 USD | -896.1% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
SGP valuation and analyst view
| Trailing P/E | -19.20 |
|---|---|
| Trailing EPS | -1.32344 USD |
| Price / book | 1.64 |
| Dividend yield | 0.00% |
| Market cap | 0.68B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is SpyGlass Pharma, Inc. Common Stock (SGP)'s next earnings date?
SpyGlass Pharma, Inc. Common Stock is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.51642 USD.
Did SGP beat earnings last quarter?
In its 2026-05-14 report, SGP posted EPS of -0.69 USD versus a -0.50311 USD estimate — a miss of 37.1%.
What is SGP's earnings track record?
Over the last 2 reported quarters with consensus data, SGP beat estimates 0 times (0%).
What is SGP's current P/E ratio and EPS?
SGP trades at a trailing P/E of -19.20 on trailing EPS of -1.3234358270898092 USD.
What do analysts rate SGP?
SGP has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.